Clinical trial
RAD001 in Recurrent Endometrial Cancer Patients
NCT00087685 · M.D. Anderson Cancer Center, Other · Completed
Key facts
| NCT number | NCT00087685 |
|---|---|
| Title | RAD001 in Recurrent Endometrial Cancer Patients |
| Official title | A Phase II Study of RAD001 in Patients With Recurrent Endometrial Cancer |
| Lead sponsor | M.D. Anderson Cancer Center, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Endometrial Cancer |
| Intervention type | Drug |
| Interventions | RAD001 |
| Enrollment | 35 |
| Start date | Jun 1, 2004 |
| Primary completion | Jan 1, 2015 |
| Completion | Jan 1, 2015 |
| First posted | Jul 14, 2004 |
| Last update posted | May 1, 2025 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: